Longevity Biotech Company

Longevity Biotech, a Philadelphia, PA-based developer of a new class of therapeutics via artificial protein technology. Longevity Biotech focuses on pharmaceutical preparation. Its hybridtides are targeted biologic-like molecules which are highly-resistant to breakdown by natural digestive enzymesand tunable to very stable molecular structures.
Technology: Metabolic Disorders
Industry: Small&Large Molecules
Headquarters: Philadelphia, Pennsylvania, United States
Founded Date: 2010
Employees Number: 1-10
Investors Number: 2
Total Funding: $836.4K
Estimated Revenue: Less than $1M
Last Funding Type: Grant

Visit Website
Register and Claim Ownership